LEARNING OBJECTIVES

At the conclusion of this activity, participants will be able to:

1. Review cardiovascular and other long-term complications following breast and prostate cancer treatment
2. Demonstrate performance of genetic risk assessment tools (UK Biobank) for predicting these complications
3. Seek collaboration for GHI-based retrospective and prospective studies